Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. DEFA14A Proxy Proxy Materials
  2. DEF 14A Proxy Proxy Statement
  3. 4 Open-market sale Chief Scientific Officer sold 11,333 shares at $20.73 ($234,985)
  4. S-8 Other Securities Offered to Employees in Benefit Plans
  5. 10-K Report Annual Report
  6. 8-K Event Results of operations
  7. 8-K Event Other events
  8. 8-K Event Other events
  9. 4 Open-market sale Chief Scientific Officer sold 11,333 shares at $24.19 ($274,171)
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. 8-K Event Material agreement · Other events
  15. SC 13G/A Stake Amended Statement of Ownership
  16. 424B5 Offering Prospectus
  17. 424B5 Offering Prospectus
  18. 4 Open-market sale Chief Scientific Officer sold 11,333 shares at $27.37 ($310,155)
  19. 8-K Event Other events
  20. SC 13G Stake Amended Statement of Ownership

Page 34 of 47 · 923 filings